Macrophages play a pivotal role in the development of newly formed vascular networks, in addition to their normal immunological functions. This research focuses on peritoneal macrophages as a novel source in cell implantation therapy for ischemic diseases. In this study, production of angiogenic growth factors by peritoneal macrophages and its in vivo effect of neovascularization were evaluated. Mononuclear cells from the peritoneal cavity (P-MNCs) enriched with macrophages were isolated and stimulated with hypoxia and interleukin-1β (IL-1β) to mimic an ischemic tissue environment in vitro. Expression of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) of mRNA in P-MNCs was apparently enhanced by hypoxic stimulation, and the production of VEGF protein was also augmented by hypoxia and IL-1β. A rat ischemic hind limb model was created and P-MNCs (8 × 10 6 /limb) were injected into the ischemic muscles. The blood flow, which was assessed using the colored microsphere method, showed that the percentage blood flow was significantly increased by P-MNCs injection 4 weeks after surgery (48.3 ± 16.8% in noninjected ischemic limb vs. 84.3 ± 13.0% in the P-MNCs-injected limb). A histological analysis revealed that the number of capillaries detected by alkaline phosphatase staining was increased in the P-MNCs group 4 weeks after injection. Furthermore, the number of α-smooth muscle actin-positive vessels also showed a significant increase following P-MNC injection. The injected P-MNCs labeled with fluorescence were detected in the interstitial space of ischemic muscles, and VEGF protein expression of the implanted cells was confirmed by immunohistochemistry. These results indicate that peritoneal macrophages stimulate capillary formation and arteriogenesis in the ischemic limbs, possibly through the production of angiogenic growth factors. These findings suggest that the physiological angiogenic property of peritoneal macrophages could therefore be utilized for neovascularization in cell implantation therapy. 211 212 HIROSE ET AL.
INTRODUCTION
distinct process: collateral growth (arteriogenesis) and capillary formation (angiogenesis) (7, 19, 40) . Recent experimental studies have demonstrated that the accumula-Macrophages are multipotent regulatory cell populations active in tissue repair processes as well as in the tion of macrophages in ischemic tissue is also closely correlated with collateral growth (3,21, 36) . Monocytes host immune defense. During physiological wound healing, macrophages phagocytose damaged tissue debris have been shown to adhere to the vascular wall during collateral vessel growth and secrete angiogenic growth and secrete various bioactive factors that influence the proliferation and differentiation of endothelial cells (15, factors at the site (3). In addition, macrophages affect the extracellular matrix composition through the produc-41). Previous reports demonstrated that a decrease in macrophage infiltration into a wound healing site leads tion of matrix metalloproteases (MMPs), thus indicating that they play a role in tissue modulation and reconstitu-to retarded wound angiogenic activity (11) . Therefore, the migration of macrophages plays an essential role for tion where arteriogenesis is promoted (2, 32) . Therefore, even in arteriogenesis, macrophages may contribute to the development of a capillary network in physiological tissue repair.
the development of collateral arteries at the ischemic site. In contrast to physiological wound healing, neovascularization in ischemic tissue is characterized by two Recruitment and activation of macrophages are en-hanced by multiple factors released from ischemic tis-the midline laparotomy. After massaging the abdominal wall for 3 min, peritoneal lavage was collected and this sue. Previous reports indicated that endothelial cells in ischemic tissues produce several chemoattractant factors process was repeated twice. The peritoneal lavage was centrifuged at 2,500 rpm at 4°C and peritoneal mononu-including inflammatory cytokines such as interleukin-1β (IL-1β) for the recruitment of macrophages (1, 5, 38) . Fur-clear cells (P-MNCs) were isolated by density gradient centrifugation (1500 × g, for 20 min) using Lympholyte-thermore, the retarded recruitment of macrophages due to the inhibition of chemoattractant factors leads im-Rat (Cedarlane, Ontario, Canada). Bone marrow cells were harvested from the femur and tibia of Lewis rats paired collateral artery growth. These studies suggest the importance of macrophage infiltration during the neo-in Hanks balanced salt solution (GIBCO, Grand Island, NY) and mononuclear cells (BM-MNCs) were isolated vascularization in the tissue ischemia.
In contrast to inflammation or wound healing, ische-by density centrifugation using Lympholyte-Rat. Red blood cells were removed by EDTA-buffered ammo-mic tissue has a reduced blood supply, thus suggesting a relatively impaired recruitment of infiltrating cells, es-nium chloride. FACS analysis was performed with FACScan (Becton Dickinson, San Jose, CA) using anti-pecially in the distal side region of ischemic tissue. Therefore, the idea of cell implantation of macrophages rat macrophage monoclonal antibodies, ED1 and ED2 (BMA Biomedicals AG, Augst, Switzerland), and goat into ischemic sites is recognized as a potentially effective strategy for direct mobilization of these cells on de-anti-mouse IgG-FITC (Zymed, San Francisco, CA). mand in ischemic tissues.
RT-PCR for mRNA Expression of IL-1β
This study focused on peritoneal macrophages bein Ischemic Hind Limbs and Angiogenic Factors cause this cell population can be obtained simply from in Peritoneal Macrophages a peritoneal lavage in a form of a mononuclear cell fraction and, therefore, are considered as a convenient source
The expression of IL-1β mRNA in ischemic and sham-operated hind limb muscle was evaluated using re-for cell implantation. In general, peritoneal macrophages are involved in the removal of microorganisms or for-verse transcriptase-polymerase chain reaction (RT-PCR). Tissue samples from the adductor muscles at 3, 7, eign bodies from the peritoneal cavity. Besides their immune function, peritoneal macrophages have been known and 14 days after surgery were homogenized in TRIzol Reagent (Invitrogen, CA) and total RNA was extracted to secrete several cytokines including angiogenic factors such as transforming growth factor-β (TGF-β), basic fi-according to the manufacturer's protocol. The expression of mRNA for bFGF and VEGF in stimulated perito-broblast growth factor (bFGF), and vascular endothelial growth factor (VEGF) upon their activation (6, 8, 42) .
neal macrophages was also measured by RT-PCR. Isolated P-MNCs were cultured in RPMI-1640 containing This study investigated the neovascularization effect of peritoneal macrophages through their production of 1% FCS under normoxic (95% air/5% CO 2 ) or hypoxic (1% O 2 /5% CO 2 in the presence of N 2 ) conditions for 24 angiogenic factors in vitro, and also the in vivo effect of cell implantation in a rat ischemic hind limb model. h. The cells were washed twice with PBS and total RNA was extracted with TRIzol Reagent. The RT-PCR was MATERIALS AND METHODS performed using an RT-PCR Kit (Takara, Japan) with Animals specific primer combinations for rat IL-1β (35) , bFGF (12) , VEGF (29), and β-actin (25): IL-1β (forward 5′-All animal protocols conformed to the Guide for the TTGAATCTATACCTGTCCTGTGTG-3′, reverse 5′-Care and Use of Laboratory Animals published by the TGACTTGGCAGAGGACAAAGG-3′); bFGF (forward US National Institutes of Health (NIH Publication No.
5′-AAGCGGCTCTACTGCAAG-3′, reverse 5′-AGCCA 85-23, revised 1996), and were approved by the institu-GACATTGGAAGAAACA-3′); VEGF (forward 5′-CC tional Animal Care and Use Committee of Kochi Uni-TCCGAAACCATGAACTTTCTGCTC-3′, reverse 5′-CA versity. Inbred male Lewis rats, 15-20 weeks old and GCCTGGCTCACCGCCTTGGCTT-3′); and β-actin (forweighing 250-300 g, were used for the experiments. All ward 5′-CGGAACCGCTCATTGCC-3′, reverse 5′-AC animals were obtained from Japan SLC, Inc. (Hama-CCACACTGTGCCCATCTA-3′). The amplified PCR matsu, Japan), and then were housed under clean condiproducts were separated by electrophoresis on a 1.5% tions at the Institute of Laboratory Animals, Kochi Uniagarose gel and detected by ethidium bromide staining. versity.
ELISA for VEGF Protein Produced by P-MNCs Isolation of Rat Peritoneal and Bone Marrow and BM-MNCs In Vitro Mononuclear Cells
All surgical procedures were performed under gen-To assess the effects of hypoxia and IL-1β on VEGF production by P-MNCs and BM-MNCs, the isolated eral anesthesia, which was induced and maintained by isoflurane. The rats were IP injected with 40 ml of phos-cells were resuspended in RPMI-1640 containing 1% FCS and incubated under normoxic or hypoxic (1% O 2 ) phate-buffered saline (PBS) through a small incision of conditions (8 × 10 6 cells/well in 24-well culture plates) Francisco, CA) were injected via the catheter into the left atrium within 30 s. After 30 s the rats were euthan-in the presence or absence of recombinant human IL-1β (100 IU/ml at final concentration, R&D Systems, Min-ized by cutting the inferior vena cava. Tissue samples of the quadriceps, adductor, semimembranous, and gastroc-neapolis, MN). After 8-h incubation the cells were washed with serum-free medium to remove the supple-nemius muscles were harvested from both limbs: left limb (operated) and right limb (nonoperated control). mented IL-1β. The cells were further cultured with RPMI-1640 containing 1% FCS under normoxic or hyp-
The muscle samples were weighed and processed for measurement of microsphere yellow dye (440 nm). Blue oxic conditions for 48 h. The VEGF levels in the culture supernatants were measured using a rat VEGF ELISA colored microspheres were used for process control according to the manufacturer's protocols (672 nm). The kit (RayBiotech, GA) according to the manufacturer's protocol.
optical density (OD) of the yellow dye extracted from these samples was measured with a spectrophotometer HUVEC Proliferation Assay and revised by recovery rate of process control. On the basis of the OD measurements, the percentage limb flow The proliferation of human umbilical vein endothelial cells (HUVECs, Cambrex, Baltimore, MD) was mea-(flow in the ischemic limb expressed as a percentage of that in the contralateral normal limb) was calculated. sured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. HUVECs (5 The percentage blood flow of the kidney (the left renal flow expressed as a percentage of the right renal flow) × 10 4 cells/well in 96-well culture plate) were stimulated with the culture supernatants of P-MNCs and BM-MNCs, was measured to confirm the mixing of microspheres (left kidney/right kidney × 100; 100.3 ± 4.4%, n = 6). which were used for the VEGF ELISA assay at a concentration of 10% for 48 h. Fresh medium with 1% FCS Histological and Immunohistochemical Analyses was used as a control. After 48-h incubation, 5 mg/ml of Vessel Numbers MTT solution (Sigma, St. Louis, MO) was added to each well and the cells were incubated for 5 h at 37°C.
For assessment of vessel formation, tissue specimens were obtained from the distal segment of the adductor The insoluble formazan product was dissolved by incubation with 10% SDS and 50% N,N-dimethyl formam-muscles in the ischemic hind limb 4 weeks after the operation. To detect capillary endothelial cells, 6-µm fro-ide for 1 h at room temperature. The absorbance of each well was measured at 570 nm.
zen sections were subjected to alkaline phosphatase (ALP) staining using the indoxyl-tetrazolium method Cell Implantation Into Rat Ischemic Hind Limb (43) and then counterstained with eosin. To evaluate arteriogenesis, immunohistochemistry was performed A rat ischemic hind limb model was prepared as described elsewhere (17) . Briefly, under general anesthe-using a primary mouse monoclonal antibody against αsmooth muscle actin (SMA) (clone 1A4; Sigma Chemi-sia, a vertical longitudinal incision was made in the left limb, extending from the inguinal ligament to a point cal Co., St. Louis, MO). Histofine Simple Stain Rat MAX-PO (Nichirei, Tokyo, Japan) was used as the just distal to the knee. The femoral artery and its branches were dissected, ligated, and completely excised through-secondary antibody. The reaction was developed with 3,3′-diaminobenzidine (DAB) substrate kit (Vector Lab-out the incision. The rats were randomly divided into four groups for subsequent cell implantation, PBS injec-oratories, Inc., Burlingame, CA), and then it was counterstained with hematoxylin. The number of capillaries, tion or non-injected control (n = 6 for each group). In the sham group, only dissection of the femoral artery SMA-positive vessels, and muscle fibers were counted in five randomly selected fields in each section (two sec-was performed. After the creation of an ischemic hind limb model, 8 × 10 6 of P-MNCs or BM-MNCs in 10 µl tions per muscle) under microscope at 200-fold magnification by a blinded observer. By definition, SMA-posi-of PBS or 10 µl of PBS alone was injected into seven points in the ischemic muscles using a 26-gauge needle:
tive vessels were tubular structures containing smooth muscle cells with patent lumen. The densities of capil-three sites in the quadriceps muscle, two sites in the adductor muscle, and two sites in the semimembranous laries and SMA-positive vessels were normalized per muscle fiber (capillary or SMA-positive vessels/muscle muscle. The right hind limb was kept intact in order to control the original blood flow.
fiber ratio) to compensate for tissue edema and muscle atrophy (34).
Measurement of Limb Blood Flow CFSE Labeling of P-MNCs and Its Detection
The colored microsphere method was used to deterin the Injected Muscle mine the regional blood perfusion of the limb muscles at 4 weeks after surgery (24) . Briefly, under general an-For the tracing of the injected P-MNCs, a fluorescent labeling method was used (23 Neovascularization is considered to correlate with the suspension followed by three washes of the cells with microenvironment of the ischemic site. In particular, in-PBS. These cells were injected into the ischemic musflammatory cytokines such as IL-1β has been recently cles and the tissue specimens were harvested 3, 7, 14,
shown to facilitate the initial step of vascular formation and 28 days after injection. The frozen tissue sections (1, 5, 38) . Even in cell transplantation therapy for ischewere also subjected to immunohistochemistry for SMA mic disease, it is conceivable that implanted cells are or immunofluorescence with mouse monoclonal antiaffected by the microenvironment of ischemic tissue to VEGF antibody (Santa Cruz Biotechnology, Inc., Santa induce their angiogenic activity. Therefore, the expres-Cruz, CA). The SMA-positive vessels were detected sion of IL-1β mRNA was confirmed in the ischemic with DAB to assess the localization of CFSE-labeled hind limb model. As shown in Figure 2 , IL-1β mRNA cells. The bound primary anti-VEGF antibody was visulevels in the sham-operated group were slightly elevated alized using Texas red-labeled secondary antibody (Mo-3 days after the operation, and decreased to the same lecular Probes, Inc., Eugene, OR). The tissue sections level as normal preoperative muscle on day 7. In confor immunofluorescence were mounted with VECTA trast, IL-1β mRNA expression was markedly enhanced SHIELD Mounting Medium with DAPI (4,6 diamidinoin the ischemic muscle 3 days after the operation and 2-phenylindole) (Vector Laboratories, Inc., Burlingame, remained elevated until day 14. These results suggest CA) for fluorescent counterstaining of DNA. The localthat a high level of IL-1β is produced and maintained in ization of implanted CFSE-labeled P-MNCs and VEGF the ischemic environment of this model. protein expression of the implanted cells were observed Production of Angiogenic Growth Factors under fluorescence microscopy.
by P-MNCs In Vitro Statistical Analysis
The production of angiogenic growth factors by P-All results are expressed as the mean ± SD. Group
MNCs was tested in vitro. Because hypoxia is an impordifferences were evaluated using the unpaired Student's tant microenvironmental factor in ischemic tissue, Pt-test. Probability values less than 0.05 were considered MNCs were incubated under hypoxic conditions (1% to be statistically significant. In an analysis of the blood oxygen) to mimic the in vivo ischemic environment. flow recovery and vessel formation, the equality of vari-After 24-h incubation under hypoxia, VEGF and bFGF ance among the five groups was analyzed using the mRNA expressions were apparently enhanced (Fig. 3A) . Bartlett test, followed by ranks using the Kruskal-Wallis This result suggested the influence of hypoxia on the test. Statistical significance was evaluated by ANOVA production of angiogenic growth factors by P-MNCs. followed by Scheffe's procedure.
Based on the observation of enhanced IL-1β expression in the ischemic hind limb, P-MNCs were further stimu-RESULTS lated by a combination of IL-1β and hypoxia. The secre-Peritoneal Macrophages in Rat Peritoneal Lavage tion of VEGF protein by P-MNCs stimulated with IL-1β and/or hypoxia was measured using an ELISA (Fig. The mononuclear cell fraction was isolated from a rat peritoneal lavage using density centrifugation. The 3B). Other studies have shown that bone marrow mononuclear cells (BM-MNCs) induce neovascularization average cell yield of the isolated P-MNCs fraction was 1.32 ± 0.22 × 10 7 cells per rat. Because peritoneal cells when implanted in ischemic sites. Therefore, VEGF production by BM-MNCs was also tested. The enhanced are composed of heterogeneous populations including macrophages, lymphocytes, eosinophils, and mast cells production of VEGF protein by P-MNCs was observed in response to hypoxic stimuli and comparable to the (16), proportions of the cell population were estimated by Wright staining (Fig. 1A, Table 1 ). After density cen-production of VEGF by BM-MNCs. Although no significant differences were observed, the VEGF production trifugation, the MNCs fraction was enriched to more than 90%. The proportion of macrophages in the isolated by P-MNCs stimulated by hypoxia was further increased by the addition of IL-1β. The production of angiogenic MNCs fraction was further determined by FACS analysis using antibodies against macrophage markers, ED1 factors by the stimulated P-MNCs was also assessed using proliferation assay with the culture supernatant ( Fig.  and ED2 , which correspond to circulating or infiltrating macrophages and resident macrophages, respectively 3C). The culture supernatants from P-MNCs and BM-MNCs stimulated both with IL-1β and hypoxia showed (9,10,16) ( Fig. 1B) . Approximately 30% and 86% of P-MNCs showed ED1 and ED2 expression, respectively, significant increase in HUVEC proliferation in comparison to the culture supernatants from nonstimulated thus indicating that most of the isolated cells were included in the macrophage lineage.
MNCs. These results suggest that P-MNCs produce an- giogenic factors in response to an ischemic microenvi-and 84.3 ± 13.0% in P-MNCs-injected limb). This blood flow recovery by the injection with P-MNCs was com-ronment.
parable to that of BM-MNCs-injected limbs.
Blood Flow Recovery of Ischemic Hind Limb by Implantation of P-MNCs Quantitative Analysis of New Vessels Formation
In order to determine whether the blood flow recov-The angiogenic property of P-MNCs was assessed in vivo by direct injection into ischemic hind limb muscles ery following the implantation of P-MNCs was induced by new vessel formation in the ischemic muscle, both (8 × 10 6 /limb). The same number of BM-MNCs was used as a comparison. The blood flow in the ischemic histological and immunohistochemical analyses were performed. Because new vessel formation is divided into limb was assessed using the colored microsphere method (Fig. 4 ). In the noninjected ischemic hind limb muscles, capillary formation and collateral artery growth, capillary density and the number of SMA-positive vessels the percentage blood flow compared with contralateral nonischemic limb was reduced 4 weeks after operation.
were assessed separately. The increase in newly formed capillaries was confirmed by ALP staining in the tissue Of the four main muscles in the hind limb, the adductor muscle showed the largest decrease in the blood flow sections of the left hind limb muscles and the number of capillaries was expressed as a capillary/muscle fiber after ischemia formation (quadriceps 74.4 ± 11.8%; adductor 48.3 ± 16.8%; semimembranous 54.0 ± 13.1%; ratio. The sections of adductor muscle in each group 4 weeks after operation are shown in Figure 5A . The cap-gastrocnemius muscle 61.6 ± 13.2%). A sham operation without the removal of the femoral artery did not affect illary/muscle fiber ratios increased significantly in the P-MNCs and BM-MNCs implanted groups in compari-the blood flow in the hind limb. The percentage blood flow in the ischemic limbs was significantly increased by implantation of P-MNCs in comparison to noninjected or PBS-injected limbs (in adductor muscles 48.3 ± 16.8% in noninjected limb, 50.2 ± 5.7% in PBS-injected limb, data from three independent experiments are indicated. son to those in the non-injected or the PBS injected group (Fig. 5B ). The increases in capillary/muscle fiber ratio observed in the other muscles were equivalent to that seen in the adductor muscle (data not shown). The number of SMA-positive vessels was evaluated in the tissue sections of the left hind limb muscles 4 weeks after the operation. The density of SMA-positive vessels was expressed as the SMA-positive vessels/muscle fiber ratio. The sections of the adductor muscle in each group 4 weeks after operation are shown in Figure 6A . The density of SMA-positive vessels in the left adductor muscles in the P-MNCs-implanted groups were significantly higher than those in both the noninjected and the PBS-injected groups (Fig. 6B ). There were no differences in the density of capillaries and SMA-positive vessels in the P-MNCs-injected muscle in comparison to the BM-MNCs-implanted muscle. These results clearly indicate that the implantation of P-MNCs actually elicits capillary formation and arteriogenesis in the ischemic muscles.
Implanted P-MNCs Localize in Interstitial Spaces of Ischemic Muscles and Express VEGF
The implanted P-MNCs were traced by fluorescence labeling with CFSE. Tissue sections of the implanted adductor muscle showed localization of the P-MNCs in interstitial spaces and perivascular area in the ischemic muscle on day 3 (Fig. 7A, a and b) . CFSE-labeled cells were observed even 4 weeks after the operation with a decrease in number (data not shown). An immunofluorescence analysis for VEGF revealed that the CFSE-labeled P-MNCs showed apparent expression of VEGF in the interstitial spaces on day 3 (Fig. 7B, a-f ). This VEGF production by the implanted cells was confirmed by im-demand in situ, should facilitate functional neovascular formation (4, 7) . Several kinds of cell population have munohistochemistry.
The enhancement of collateral vascular formation is been shown to elicit neovascularization in experimental studies (20, 23) . Clinical trials using bone marrow cells an intriguing approach as a treatment for severe ischemic cardiovascular disease, especially when there is no showed a blood flow recovery in ischemic heart diseases and peripheral artery diseases (18, 39) by the direct injec-other option. The concept of therapeutic angiogenesis is intended directly for the promotion of collateral growth tion of the cells. Because macrophages play a key role in physiological tissue repair, including the recovery of by the local administration of angiogenic growth factors in the form of proteins (26,37), by gene transfer (22,28, the tissue blood supply, this study focused on the peritoneal macrophages as an alternative cell source for neo-33), or by cell implantation (13, 18, 39) . Because establishing a stable vascular network is a complex process vascularization. The basic mechanisms in neovasularization comprise involving a number of growth factors and cell interactions, the administration of a single factor may be insuf-the proliferation of capillaries in the ischemic area (angiogenesis) and maturation of preexisting collateral ves-ficient to obtain the optimal effects. Therefore, the transfer of cells, which can produce multiple factors on sels (arteriogenesis) (7, 19, 40) . Arteriogenesis is essen- tial to increase blood supply from the proximal site of Our experiments showed the sustained increase in IL-1β expression in the ischemic limb muscle. This local the ischemic area. Angiogenesis is also an important process toward a better perfusion and oxygenation of enhancement of IL-1β has been reported in other systems (5, 38) and its biological significance in neovascu-poststenotic tissue (27) . Therefore, providing blood supply through collateral growth with simultaneous recov-larization has been clearly demonstrated using IL-1β knocked out mice (1) . In this in vitro analysis, there was ery of the capillary bed might be necessary for better oxygen delivery to the ischemic tissue. In the present an increase in VEGF secretion by P-MNCs in response to both IL-1β and the hypoxic environment. HUVECs results, the number of both capillaries and collateral artery was increased in the P-MNCs-injected muscles.
proliferation assay also showed that production of angiogenic factors was increased by hypoxia and IL-1β. Hence, in this model, injected P-MNCs enhanced blood distribution in the ischemic muscle probably by promot-Therefore, the environment in the ischemic tissue such as hypoxia and IL-1β might trigger the induction of an-ing microperfusion through capillary formation as well as increasing blood supply by collateral artery growth giogenic action of the implanted peritoneal macrophages in vivo. from the proximal occlusion site. Moreover, the efficacy of the blood flow recovery was comparable to that of The angiogenic property of peritoneal macrophages has been described in a pathological analysis of endome-BM-MNCs, thus indicating the predominant role that the P-MNCs play in neovascularization.
triosis in the gynecological field (14,30). High levels of VEGF production by peritoneal macrophages in the pa-the P-MNCs implantation was induced by the activity of both macrophage populations implanted into the ische-tients with endometriosis have been reported (31). The current data provide the first evidence that the angio-mic site. Peritoneal macrophages are a novel origin for cell genic properties of the peritoneal macrophages can induce neovascularization by cell injection into ischemic collection for autologous cell implantations. The P-MNCs fraction can be isolated simply from a peritoneal tissues.
Macrophages are generally divided into circulating or lavage. This concept of cell therapy using peritoneal macrophages might be utilized in combination with sur-recruited macrophages (ED1) and resident tissue macrophages (ED2). In these results, the isolated P-MNCs in-gical revasularization with laparotomy, such as a coronary bypass grafting using a gastroepiploic artery. cluded both ED1 cells and ED2 cells. Interestingly, the dominant proliferation of ED2-positive resident macro-In conclusion, these findings show the prominent neovascularization activity of peritoneal macrophages, phages has been shown to occur at the site of arteriogenesis in the ischemic hind limb model, thus indicating thereby suggesting the possibility of developing a new strategy for cell therapy in ischemic cardiovascular dis-that ED2-positive resident macrophages affect neovascularization even if there is an impaired macrophage re-eases. cruitment (21). Therefore, it is conceivable that the en-ACKNOWLEDGMENTS: This study was supported in part by institutional grants of the Selective Research Projects in Kochi hanced new vessels formation observed in response to 
